Laurent Fischer - 04 Jun 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
04 Jun 2021
Transactions value $
$0
Form type
4
Filing time
08 Jun 2021, 16:33:49 UTC
Next filing
10 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +17K $0.00 17K 04 Jun 2021 Common Stock 17K $16.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting.